Dr. Matthew Bott, MD

Claim this profile

Memorial Sloan Kettering

Studies Non-Small Cell Lung Cancer
Studies Lung Cancer
2 reported clinical trials
5 drugs studied

Area of expertise

1Non-Small Cell Lung Cancer
Matthew Bott, MD has run 1 trial for Non-Small Cell Lung Cancer. Some of their research focus areas include:
Stage I
Stage III
Stage II
2Lung Cancer
Matthew Bott, MD has run 1 trial for Lung Cancer. Some of their research focus areas include:
Stage I
Stage III
Stage II

Affiliated Hospitals

Image of trial facility.
Memorial Sloan Kettering
Image of trial facility.
Memorial Sloan Kettering Cancer Center (All Protocol Activities)

Clinical Trials Matthew Bott, MD is currently running

More about Matthew Bott, MD

Clinical Trial Related1 year of experience running clinical trials · Led 2 trials as a Principal Investigator · 1 Active Clinical Trial
Treatments Matthew Bott, MD has experience with
  • Carboplatin
  • Nivolumab
  • Nivolumab And Ipilimumab
  • Paclitaxel
  • NovoTTF-200T System
Breakdown of trials Matthew Bott, MD has run
Non-Small Cell Lung Cancer
Lung Adenocarcinoma

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Matthew Bott, MD specialize in?
Matthew Bott, MD focuses on Non-Small Cell Lung Cancer and Lung Cancer. In particular, much of their work with Non-Small Cell Lung Cancer has involved Stage I patients, or patients who are Stage III.
Is Matthew Bott, MD currently recruiting for clinical trials?
Yes, Matthew Bott, MD is currently recruiting for 1 clinical trial in New York New York. If you're interested in participating, you should apply.
Are there any treatments that Matthew Bott, MD has studied deeply?
Yes, Matthew Bott, MD has studied treatments such as Carboplatin, Nivolumab, Nivolumab and Ipilimumab.
What is the best way to schedule an appointment with Matthew Bott, MD?
Apply for one of the trials that Matthew Bott, MD is conducting.
What is the office address of Matthew Bott, MD?
The office of Matthew Bott, MD is located at: Memorial Sloan Kettering, New York, New York 10065 United States. This is the address for their practice at the Memorial Sloan Kettering.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security